Wells Fargo’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.01M | Sell |
37,756
-5,980
| -14% | -$319K | ﹤0.01% | 2906 |
|
2025
Q1 | $1.77M | Sell |
43,736
-18,131
| -29% | -$734K | ﹤0.01% | 2901 |
|
2024
Q4 | $1.72M | Buy |
61,867
+7,587
| +14% | +$211K | ﹤0.01% | 2908 |
|
2024
Q3 | $1.56M | Buy |
54,280
+24,829
| +84% | +$712K | ﹤0.01% | 2926 |
|
2024
Q2 | $691K | Buy |
29,451
+9,325
| +46% | +$219K | ﹤0.01% | 3386 |
|
2024
Q1 | $508K | Buy |
20,126
+5,763
| +40% | +$146K | ﹤0.01% | 3541 |
|
2023
Q4 | $335K | Sell |
14,363
-31,243
| -69% | -$730K | ﹤0.01% | 3771 |
|
2023
Q3 | $2.31M | Sell |
45,606
-2,845
| -6% | -$144K | ﹤0.01% | 2507 |
|
2023
Q2 | $2.26M | Buy |
48,451
+11,834
| +32% | +$553K | ﹤0.01% | 2658 |
|
2023
Q1 | $1.4M | Buy |
36,617
+34,800
| +1,915% | +$1.33M | ﹤0.01% | 2949 |
|
2022
Q4 | $99.6K | Buy |
1,817
+82
| +5% | +$4.49K | ﹤0.01% | 4243 |
|
2022
Q3 | $59K | Sell |
1,735
-67
| -4% | -$2.28K | ﹤0.01% | 4571 |
|
2022
Q2 | $17K | Sell |
1,802
-2,286
| -56% | -$21.6K | ﹤0.01% | 5232 |
|
2022
Q1 | $58K | Sell |
4,088
-8,862
| -68% | -$126K | ﹤0.01% | 5248 |
|
2021
Q4 | $274K | Buy |
12,950
+12,473
| +2,615% | +$264K | ﹤0.01% | 4737 |
|
2021
Q3 | $11K | Buy |
477
+250
| +110% | +$5.77K | ﹤0.01% | 5831 |
|
2021
Q2 | $6K | Sell |
227
-150
| -40% | -$3.97K | ﹤0.01% | 5930 |
|
2021
Q1 | $11K | Sell |
377
-29,645
| -99% | -$865K | ﹤0.01% | 5938 |
|
2020
Q4 | $774K | Buy |
30,022
+23,629
| +370% | +$609K | ﹤0.01% | 4140 |
|
2020
Q3 | $196K | Sell |
6,393
-14,941
| -70% | -$458K | ﹤0.01% | 4805 |
|
2020
Q2 | $532K | Buy |
21,334
+15,189
| +247% | +$379K | ﹤0.01% | 4170 |
|
2020
Q1 | $130K | Buy |
6,145
+2,981
| +94% | +$63.1K | ﹤0.01% | 4745 |
|
2019
Q4 | $70K | Buy |
3,164
+2,778
| +720% | +$61.5K | ﹤0.01% | 5181 |
|
2019
Q3 | $9K | Buy |
+386
| New | +$9K | ﹤0.01% | 5554 |
|